{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:02:38Z","timestamp":1794589358625,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patient journey maps are increasingly used as a tool that enables healthcare providers to refine their service provision to best meet patient needs. We developed a cervical dystonia patient journey map (CDPJM) that describes the holistic patient experience from pre-diagnosis through to long-term treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The CDPJM was developed in 2 stages; a patient survey (open questions and multichoice) of 15 patients with CD was conducted to inform the design of the CDPJM, which was then refined and validated by an expert-patient focus group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Qualitative analysis of the patient survey supported five key stages of the patient journey: symptom onset, diagnosis and therapeutic relationship with healthcare professionals, initiation of care for CD, start of CD treatment, and living with treated CD. Following symptom onset, survey respondents described having multiple visits to their family doctor who prescribed strong pain killers and muscle relaxants and referred their patient to up to 10 different specialists for diagnosis. Over half (53.3%) of respondents had received\u2009\u2265\u20091 misdiagnosis. Respondents reported relief at having a diagnosis but a lack of understanding of the prognosis and treatment options; 46.7% said their neurologist did not spend enough time addressing their concerns. Survey respondents reported using a variety of alternative sources of information, including the internet (86.7%), self-help groups (66.7%) and information leaflets provided by health care professionals (60.0%). While botulinum toxin (BoNT) was consistently discussed as the main treatment option, some neurologists also mentioned physiotherapy, counselling, and other complementary approaches. However, patients were often left to seek complementary services themselves. Patients reported a \u2018rollercoaster\u2019 of relief with BoNT treatment with symptoms (and subsequent impact on daily life) returning towards the end of an injection cycle. <jats:italic>\u201cWhen BoNT works well I can return to an almost normal life \u2026 when the injections stop working so well, I have to rest more and avoid going to work and experience life restrictions.\u201d<\/jats:italic><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We present the first patient journey map for CD that can be used to guide local service mapping and to compare current provision with what patients say they want and need.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02270-4","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T10:02:33Z","timestamp":1647856953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Development of a patient journey map for people living with cervical dystonia"],"prefix":"10.1186","volume":"17","author":[{"given":"Monika","family":"Benson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash P.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Cavillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Cuffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9803-7183","authenticated-orcid":false,"given":"Holm","family":"Graessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"issue":"4","key":"2270_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00702-021-02314-2","volume":"128","author":"K Gr\u00fctz","year":"2021","unstructured":"Gr\u00fctz K, Klein C. Dystonia updates: definition, nomenclature, clinical classification, and etiology. J Neural Transm. 2021;128(4):395\u2013404.","journal-title":"J Neural Transm"},{"issue":"7","key":"2270_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, et al. Phenomenology and classification of dystonia: A consensus update. Mov Disord. 2013;28(7):863\u201373.","journal-title":"Mov Disord"},{"issue":"3","key":"2270_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/mds.27927","volume":"35","author":"SC LaHue","year":"2020","unstructured":"LaHue SC, Albers K, Goldman S, Lo RY, Gu Z, Leimpeter A, et al. Cervical dystonia incidence and diagnostic delay in a multiethnic population. Mov Disord. 2020;35(3):450\u20136.","journal-title":"Mov Disord"},{"issue":"2","key":"2270_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/mds.870060206","volume":"6","author":"J Chan","year":"1991","unstructured":"Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord. 1991;6(2):119\u201326.","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"2270_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0733-8619(08)80003-5","volume":"26","author":"M Stacy","year":"2008","unstructured":"Stacy M. Epidemiology, clinical presentation, and diagnosis of cervical dystonia. Neurol Clin. 2008;26(Suppl 1):23\u201342.","journal-title":"Neurol Clin"},{"issue":"12","key":"2270_CR6","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/mds.20670","volume":"20","author":"IM Skogseid","year":"2005","unstructured":"Skogseid IM, Roislien J, Claussen B, Kerty E. Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia. Mov Disord. 2005;20(12):1604\u20139.","journal-title":"Mov Disord"},{"issue":"5","key":"2270_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jnnp.72.5.608","volume":"72","author":"Y Ben-Shlomo","year":"2002","unstructured":"Ben-Shlomo Y, Camfield L, Warner T. What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry. 2002;72(5):608\u201314.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"2270_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clineuro.2008.09.023","volume":"111","author":"T Pekmezovic","year":"2009","unstructured":"Pekmezovic T, Svetel M, Ivanovic N, Dragasevic N, Petrovic I, Tepavcevic DK, et al. Quality of life in patients with focal dystonia. Clin Neurol Neurosurg. 2009;111(2):161\u20134.","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"2270_CR9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s00415-002-0733-1","volume":"249","author":"J Muller","year":"2002","unstructured":"Muller J, Kemmler G, Wissel J, Schneider A, Voller B, Grossmann J, et al. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol. 2002;249(7):842\u20136.","journal-title":"J Neurol"},{"issue":"1","key":"2270_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","volume":"18","author":"A Albanese","year":"2011","unstructured":"Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011;18(1):5\u201318.","journal-title":"Eur J Neurol"},{"key":"2270_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.0000000000002560","volume":"86","author":"DM Simpson","year":"2016","unstructured":"Simpson DM, Hallett M, Ashman EJ. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Neurology. 2016;86:1\u20139.","journal-title":"Neurology"},{"key":"2270_CR12","unstructured":"World Health Organization. Patient Engagement: Technical Series on Safer Primary Care 2016. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/252269\/9789241511629-eng.pdf."},{"key":"2270_CR13","unstructured":"EFNA, Optimising patient involvement in neuroscience research. 2020 \u2013 European Federation of Neurological Associations. https:\/\/www.efna.net\/wp-content\/uploads\/2020\/05\/EFNA-Report_Patient-Inolvement-in-Neuroscience-Research.pdf."},{"key":"2270_CR14","doi-asserted-by":"crossref","unstructured":"Comella C, Bhatia K. An international survey of patients with cervical dystonia. J Neurol. 2015;262(4).","DOI":"10.1007\/s00415-014-7586-2"},{"issue":"3","key":"2270_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00415-020-10217-7","volume":"268","author":"C Comella","year":"2021","unstructured":"Comella C, Ferreira JJ, Pain E, Azoulai M, Om S. Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia. J Neurol. 2021;268(3):903\u201312.","journal-title":"J Neurol"},{"issue":"3","key":"2270_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3111\/13696998.2011.653726","volume":"15","author":"KD Sethi","year":"2012","unstructured":"Sethi KD, Rodriguez R, Olayinka B. Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia. J Med Econ. 2012;15(3):419\u201323.","journal-title":"J Med Econ"},{"issue":"2","key":"2270_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41431-019-0555-6","volume":"28","author":"M Bolz-Johnson","year":"2020","unstructured":"Bolz-Johnson M, Meek J, Hoogerbrugge N. \u201cPatient Journeys\u201d: improving care by patient involvement. Eur J Hum Genet EJHG. 2020;28(2):141\u20133.","journal-title":"Eur J Hum Genet EJHG"},{"key":"2270_CR18","doi-asserted-by":"crossref","unstructured":"Arias M, Rojas E, Aguirre S, Cornejo F, Munoz-Gama J, Sep\u00falveda M, et al. Mapping the patient's journey in healthcare through process mining. Int J Environ Res Public Health. 2020;17(18).","DOI":"10.3390\/ijerph17186586"},{"issue":"1","key":"2270_CR19","first-page":"82","volume":"3","author":"L Simonse","year":"2019","unstructured":"Simonse L, Albayrak A, Starre S. Patient journey method for integrated service design. Des Health. 2019;3(1):82\u201397.","journal-title":"Des Health"},{"key":"2270_CR20","unstructured":"Public Health England. Improvement Leaders\u2019 Guide Process mapping, analysis and redesign. https:\/\/www.england.nhs.uk\/improvement-hub\/wp-content\/uploads\/sites\/44\/2017\/11\/ILG-1.2-Process-Mapping-Analysis-and-Redesign.pdf."},{"issue":"1","key":"2270_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13023-020-01641-z","volume":"16","author":"AEM Post","year":"2021","unstructured":"Post AEM, Klockgether T, Landwehrmeyer GB, Pandolfo M, Arnesen A, Reinhard C, et al. Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases. Orphanet J Rare Dis. 2021;16(1):135.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"2270_CR22","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/ene.14302","volume":"27","author":"C Painous","year":"2020","unstructured":"Painous C, van Os NJH, Delamarre A, Michailoviene I, Marti MJ, van de Warrenburg BP, et al. Management of rare movement disorders in Europe: outcome of surveys of the European Reference Network for Rare Neurological Diseases. Eur J Neurol. 2020;27(8):1493\u2013500.","journal-title":"Eur J Neurol"},{"key":"2270_CR23","doi-asserted-by":"crossref","unstructured":"Reinhard C, Bachoud-L\u00e9vi A-C, B\u00e4umer T, Bertini E, Brunelle A, Buizer AI, et al. The European reference network for rare neurological diseases. Front Neurol. 2021;11(1753).","DOI":"10.3389\/fneur.2020.616569"},{"issue":"6","key":"2270_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S1474-4422(18)30143-1","volume":"17","author":"A Burton","year":"2018","unstructured":"Burton A. How do we fix the shortage of neurologists? Lancet Neurol. 2018;17(6):502\u20133.","journal-title":"Lancet Neurol"},{"issue":"11","key":"2270_CR25","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.clinthera.2019.09.007","volume":"41","author":"C Colosimo","year":"2019","unstructured":"Colosimo C, Bhidayasiri R, Fheodoroff K, Bhatia K, Chung TM, Landreau T, et al. Management of spastic paresis and cervical dystonia: access to therapeutic innovations through an international program of practical courses. Clin Ther. 2019;41(11):2321-30.e4.","journal-title":"Clin Ther"},{"issue":"3","key":"2270_CR26","doi-asserted-by":"publisher","first-page":"e009750","DOI":"10.1136\/bmjopen-2015-009750","volume":"6","author":"B Heckemann","year":"2016","unstructured":"Heckemann B, Wolf A, Ali L, Sonntag SM, Ekman I. Discovering untapped relationship potential with patients in telehealth: a qualitative interview study. BMJ Open. 2016;6(3):e009750.","journal-title":"BMJ Open."},{"issue":"1","key":"2270_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s12913-017-2630-4","volume":"17","author":"AE Sharma","year":"2017","unstructured":"Sharma AE, Knox M, Mleczko VL, Olayiwola JN. The impact of patient advisors on healthcare outcomes: a systematic review. BMC Health Serv Res. 2017;17(1):693.","journal-title":"BMC Health Serv Res"},{"key":"2270_CR28","doi-asserted-by":"crossref","unstructured":"F\u00f8nhus MS, Dalsb\u00f8 TK, Johansen M, Fretheim A, Skirbekk H, Flottorp SA. Patient-mediated interventions to improve professional practice. Cochrane Database Syst Rev. 2018;9(9):Cd012472.","DOI":"10.1002\/14651858.CD012472.pub2"},{"key":"2270_CR29","unstructured":"EURORDIS. Solve-RD infographic on the patient journey to diagnosis. https:\/\/www.eurordis.org\/publication\/diagnosisjourneyinfographic. Last accessed September 2021."},{"key":"2270_CR30","doi-asserted-by":"publisher","first-page":"117015","DOI":"10.1016\/j.jns.2020.117015","volume":"416","author":"C Colosimo","year":"2020","unstructured":"Colosimo C, Charles D, Misra VP, Maisonobe P, Om S. Group IICs. Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: findings from a prospective, observational study. J Neurol Sci. 2020;416:117015.","journal-title":"J Neurol Sci."},{"key":"2270_CR31","doi-asserted-by":"publisher","first-page":"100063","DOI":"10.1016\/j.prdoa.2020.100063","volume":"3","author":"RM Trosch","year":"2020","unstructured":"Trosch RM, Misra VP, Maisonobe P, Om S. Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice. Clin Parkinsonism Relat Dis. 2020;3:100063.","journal-title":"Clin Parkinsonism Relat Dis"},{"issue":"12","key":"2270_CR32","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1007\/s00415-019-09527-2","volume":"266","author":"C Colosimo","year":"2019","unstructured":"Colosimo C, Charles D, Misra VP, Maisonobe P, Om S. Group IICs. How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study. J Neurol. 2019;266(12):3038\u201346.","journal-title":"J Neurol."},{"key":"2270_CR33","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3233\/JPD-202078","volume":"10","author":"DLM Radder","year":"2020","unstructured":"Radder DLM, Nonnekes J, van Nimwegen M, Eggers C, Abbruzzese G, Alves G, et al. Recommendations for the organization of multidisciplinary clinical care teams in Parkinson\u2019s disease. J Parkinsons Dis. 2020;10:1087\u201398.","journal-title":"J Parkinsons Dis"},{"key":"2270_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.47795\/FXOK4296","volume":"19","author":"T Mace","year":"2020","unstructured":"Mace T, Peel C. Parkinson\u2019s Hub: an integrated pathway for people with Parkinson\u2019s and frailty. ACNR. 2020;19:38\u201341.","journal-title":"ACNR"},{"issue":"2","key":"2270_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/jnnp.2011.241604","volume":"11","author":"B Post","year":"2011","unstructured":"Post B, van der Eijk M, Munneke M, Bloem BR. Multidisciplinary care for Parkinson\u2019s disease: not if, but how! Pract Neurol. 2011;11(2):58\u201361.","journal-title":"Pract Neurol"},{"key":"2270_CR36","first-page":"1071","volume":"270","author":"M Sijm-Eeken","year":"2020","unstructured":"Sijm-Eeken M, Zheng J, Peute L. Towards a lean process for patient journey mapping - a case study in a large academic setting. Stud Health Technol Inform. 2020;270:1071\u20135.","journal-title":"Stud Health Technol Inform"},{"key":"2270_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/JHL.S288966","volume":"13","author":"T Bharatan","year":"2021","unstructured":"Bharatan T, Devi R, Huang PH, Javed A, Jeffers B, Lansberg P, et al. A methodology for mapping the patient journey for noncommunicable diseases in low- and middle-income countries. J Healthc Leadersh. 2021;13:35\u201346.","journal-title":"J Healthc Leadersh"},{"key":"2270_CR38","first-page":"1957","volume":"2015","author":"L Kendall","year":"2015","unstructured":"Kendall L, Mishra SR, Pollack A, Aaronson B, Pratt W. Making background work visible: opportunities to address patient information needs in the hospital. AMIA Annu Symp Proc. 2015;2015:1957\u201366.","journal-title":"AMIA Annu Symp Proc"},{"key":"2270_CR39","first-page":"200","volume":"2019","author":"E Agapie","year":"2020","unstructured":"Agapie E, Kendall L, Mishra SR, Haldar S, Khelifi M, Pollack A, et al. Using priorities of hospitalized patients and their caregivers to develop personas. AMIA Annu Symp Proc. 2020;2019:200\u20139.","journal-title":"AMIA Annu Symp Proc"},{"issue":"5","key":"2270_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/qshc.2005.016527","volume":"15","author":"P Bate","year":"2006","unstructured":"Bate P, Robert G. Experience-based design: from redesigning the system around the patient to co-designing services with the patient. Qual Saf Health Care. 2006;15(5):307\u201310.","journal-title":"Qual Saf Health Care"},{"issue":"4","key":"2270_CR41","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.2196\/jmir.1718","volume":"13","author":"CF Van Uden-Kraan","year":"2011","unstructured":"Van Uden-Kraan CF, Drossaert CHC, Taal E, Smit WM, Bernelot Moens HJ, Van de Laar MAFJ. Determinants of engagement in face-to-face and online patient support groups. J Med Internet Res. 2011;13(4):e106.","journal-title":"J Med Internet Res."},{"key":"2270_CR42","unstructured":"https:\/\/rarediseases.org\/rare-diseases\/cervical-dystonia\/. Last accessed January 2022."},{"key":"2270_CR43","doi-asserted-by":"crossref","unstructured":"Supnet ML, Acuna P, Carr SJ, Kristoper de Guzman J, Al Qahtani X, Multhaupt-Buell T, et al. Isolated Cervical Dystonia: Management and Barriers to Care. Frontiers in Neurology. 2020;11.","DOI":"10.3389\/fneur.2020.591418"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02270-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02270-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02270-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T10:11:42Z","timestamp":1647857502000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02270-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2270"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02270-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical Research Ethics Committee or Independent Review Board approval was not required for the patient survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Monika Benson, Carola Reinhard and Holm Graessner are members of the European Reference Network for Rare Neurological Diseases and have no further conflicts to report. Alberto Albanese reports research support from Ipsen, Merz. He is the Specialty Chief Editor Frontiers in Neurology \u2013 Movement Disorders Section. Kailash P Bhatia has received grant support from EU Horizon 2020. He receives royalties from publication of the Oxford Specialist Handbook Parkinson\u2019s Disease and Other Movement Disorders (Oxford University Press, 2008), of Marsden\u2019s Book of Movement Disorders (Oxford University Press, 2012), and of Case Studies in Movement Disorders\u2013Common and uncommon presentations (Cambridge University Press, 2017). He has received honoraria\/personal compensation for participating as consultant\/scientific board member from Ipsen, Allergan, and honoraria for speaking at meetings from Allergan, Ipsen, and the International Parkinson\u2019s Disease and Movement Disorders Society. Pascale Cavillon and Lorraine Cuffe are employed by Ipsen. Kathrin K\u00f6nig is employed by PARTNERSEITZ GmbH which was contracted to develop the CDPJM (funded by Ipsen).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}